Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Account Payables (2016 - 2025)

Conmed's Change in Account Payables history spans 16 years, with the latest figure at -$13.6 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 2053.8% year-over-year to -$13.6 million; the TTM value through Dec 2025 reached -$9.7 million, down 166.26%, while the annual FY2025 figure was -$9.7 million, 166.26% down from the prior year.
  • Change in Account Payables reached -$13.6 million in Q4 2025 per CNMD's latest filing, down from $5.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $13.0 million in Q1 2024 to a low of -$13.6 million in Q4 2025.
  • Average Change in Account Payables over 5 years is $1.9 million, with a median of $2.4 million recorded in 2023.
  • Peak YoY movement for Change in Account Payables: surged 1858.37% in 2022, then tumbled 2053.8% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $11.1 million in 2021, then tumbled by 110.56% to -$1.2 million in 2022, then surged by 672.55% to $6.7 million in 2023, then crashed by 109.41% to -$632000.0 in 2024, then crashed by 2053.8% to -$13.6 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Change in Account Payables are -$13.6 million (Q4 2025), $5.5 million (Q3 2025), and $5.7 million (Q2 2025).